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Alveolar echinococcosis (AE) is a very severe zoonotic helminthic disease, which is fatal if patients are not appropriately diagnosed and subsequently treated. 1 AE is characterized by a chronically progressing hepatic damage caused by the continuous proliferation of the larval stage (metacestode) of Echinococcus multilocularis (E. multilocularis), 2 that behaves like a slowly growing and metastasizing liver cancer, thus progressively also invading other host tissues and organs such as lungs and brain, among others. 3 For the treatment of AE, surgery is, so far, the only potentially curative option. Inoperable AE cases must undergo long-term chemotherapy, often lifelong. 4 Extensive animal experimentations and observations in human patients suffering from AE have demonstrated that ABZ and MBZ exhibit a parasitostatic rather than a parasiticidal effect. 4, 5 Therefore, recurrence rates after interruption of therapy are high. Beside the inconvenience of a daily and longterm drug administration, some patients experience side effects
Summary
The growth potential of the tumour-like Echinococcus multilocularis metacestode (causing alveolar echinococcosis, AE) is directly dependent upon the nature/function of the periparasitic adaptive host immune-mediated processes. PD-1/PD-L1 pathway (programmed cell death 1), which inhibits lymphocytic proliferation in tumour development, is over-expressed at the chronic stage of AE. We tested the impact of a PD-1/PD-L1 pathway blockade on the outcome of both chronic AE (intraperitoneal metacestode inoculation, secondary AE and SAE) and acute AE (peroral egg infection, primary AE and PAE). To assess the parasite proliferation potential, we measured parasite mass weight for SAE and liver lesion number for PAE. In both models, the parasite load was significantly decreased in response to anti-PD-L1 antibody treatment. In SAE, anti-PDL1 administration was associated with increased Th1 response parameters and decreased Treg responses, while in PAE anti-PDL1 administration was associated with fewer lesions in the liver and decreased Treg/Th2 responses. Our findings highly suggested that a PD-1/PD-L1 pathway blockade triggered the host immune responses in favour of an immune-mediated control of E. multilocularis proliferation. Based on this, future studies that combine PD-1/PD-L1 blockade with a parasitostatic albendazole medication may yield in a putatively curative therapeutic approach to control alveolar echinococcosis.
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| MATERIAL S AND ME THODS

| Ethics statement
The animal studies were performed in strict accordance with the recommendations of the Swiss Guidelines for the Care and Use of Laboratory Animals. The protocol was approved by the governmental Commission for Animal Experimentation of the Canton of Bern (approval no. BE112/14 and BE112/17). Intraperitoneal infection with E. multilocularis metacestodes was performed as previously described. 24 Briefly, E. multilocularis (H95) was isolated and maintained by serial passages (vegetative transfer) in C57BL/6 mice as previously described. 24 In order to prepare the infection material for mice, metacestode tissue was obtained from previously infected mice by aseptic removal from the peritoneal cavity. After grinding the tissue through a sterile 50 μm sieve, approximately 100 freshly prepared vesicular cysts were suspended in 100 μL sterile PBS (Gibco, Basel, Switzerland) and intraperitoneally injected. Each experimental group included six animals unless otherwise stated. Control mice received 100 μL of sterile PBS only.
| Mice
Upon end of experiments, mice were sacrificed by CO 2 -euthanasia at 4 weeks post infection (corresponding to middle stage of chronic infection). Parasite tissues were dissected and, if present, fat and connective tissues were carefully removed for subsequent determination of the parasite mass.
PD-L1 blocking
All mice belonging to the PD-L1 blocking group (AE αPD-L1) re-
Lebanon, NH, USA) dissolved in 100 μL PBS at 1 day before infection and maintained for 4 weeks, with a subsequent frequency of one injection/mouse every 4 days. 25 All mice were daily monitored for survival and morbidity.
| Experiment 2. PD-1/PD-L1 pathway blockade against PAE
Parasite and oral infection of mice
Echinococcus multilocularis eggs were isolated from a naturally E. multilocularis-infected dog euthanized at the Small Animal Clinic of the Vetsuisse Faculty due to a non-infectious health problem, infection was detected upon routine necropsy investigation by pathologists. 26, 27 In order to prepare the infection material for mice, the dog intestine was removed under appropriate safety precautions and cut into four pieces. After opening the dog intestine, the wormcontaining mucus sections were scraped out, put into petri dishes containing sterile water. Subsequently, the mucosal suspension was serially filtered through a 500 μmØ and then 250 μmØ metal sieve, by concurrently disrupting the worms with an inversed 2 mL sy- The number of liver lesions was then macroscopically assessed as described elsewhere.
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PD-L1 blocking
All mice belonging to the PD-L1 blocking group (AE αPD-L1) received 200 μg of anti-PD-L1 MAb i.p. (BioXcell, clone 10F.9G2) dissolved in 100 μL PBS at 1 day before infection and maintained for 2 weeks, with a subsequent frequency of one injection/mouse every 4 days. 25 All mice were daily monitored for survival and morbidity.
| Total RNA extraction and qRT-PCR
Total RNA was isolated from spleens using the Qiagen RNeasy MiniKit according to the manufacturer's instructions. The quality of the isolated RNA was determined with a NanoDrop ND 1000 (NanoDrop to 30 seconds). Fluorescence was measured in every cycle, and a melting curve was analyzed after the PCR by increasing the temperature from 55 to 95°C in 0.5°C increments. The primers used were described earlier, 29 and mRNA levels of different cytokines were quantified relative to the mRNA level of housekeeping gene β-actin.
| Cell preparation and flow cytometry
Spleen cells from naïve (control) and E. multilocularis-infected mice were collected by splenic grinding, each step with 5 mL RPMI-1640.
Cells were subsequently washed twice with and then resuspended in RPMI-1640 (Gibco) for cell staining.
Aliquots of 10 6 cells/100 μL of staining buffer per well were in- Data represent mean ± SD of a total of six mice in each group. Comparison between groups was performed using a one-way ANOVA with Bonferroni's multiple comparison post-test for statistical analysis. *P < 0.006. Control: non-infected wild-type mice; SAE-WT: E. multilocularis secondarily infected wild-type mice; SAE-αPD-L1: E. multilocularis secondarily infected wild-type mice treated with anti-PD-L1 MAb resulted in a significantly lower number of liver lesions, as compared to the infected non-treated group (PAE-WT; P < 0.05; Figure 2A ).
| Statistical analyses
| Decreased Treg immune response in PAE mice with PD-1/PD-L1 pathway blockade
Peroral infection was associated with an increase of CD4 
| Decreased Th2 immune response in PAE mice with PD-1/PD-L1 pathway blockade
A significant increase of CD4 + IL-4 + frequency in the spleen was observed at 2 weeks post oral infection with E. multilocularis eggs No difference for IFN-γ expression levels was observed in the spleen from PAE-WT mice treated with anti-PD-L1 MAb, when compared to untreated PAE-WT mice ( Figure 3F ; P < 0.025).
| Innate immune responses are activated in PAE mice but not altered with PD-1/PD-L1 pathway blockade
By flow cytometry, a significant increase of NK cell number in the spleen was observed in PAE mice compared to infectionfree WT controls ( Data represent mean ± SD of three independent experiments of a total of six mice in each group. Comparison between groups was performed using a one-way ANOVA for statistical analysis. *P < 0.025. Control: non-infected wild-type mice; PAE-WT: Echinococcus multilocularis primarily infected wild-type mice; PAE-αPD-L1: E. multilocularis primarily infected wild-type mice treated with anti-PD-L1 MAb parasite load (i.p. infection, SAE) not only when Foxp3 + Tregs were depleted preventively before E. multilocularis infection, 38 but also when they were depleted therapeutically when the infection was already established (oral infection, PAE). 39 The significantly smaller average lesion size in the liver due to Foxp3 + Tregs depletion in PAE was associated with a higher Th1 immune response, a lower IL-10 production and upregulation of APC activation. 39 The late infection of both SAE and PAE was characterized by a strong Foxp3 expression and weak expression of most mediators, suggesting that their production is suppressed by Tregs. 39 shown to be partially 46 or totally 47 effective for controlling parasite growth; IFNα-2α was able to effectively suppress AE occurrence via an enhanced Th1 and a lower Th2 immunity in the mouse model, 48 and IFNα-2α administration was reported to reduce AE lesion size in one patient co-infected with HCV. 49 However, it was never tested as therapeutic agents whether this was applicable to larger numbers of human AE patients. Alveolar echinococcosis still remains a severe life-threatening disease without a fully curative therapy, and new treatment options are urgently needed. 
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